Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-03-10
1999-12-07
Johnson, Nancy A.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
4353201, 514 44, 536 231, 536 2353, 536 2372, 536 241, A61K 4800, C07H 2104, C12N 1562, C12N 1513
Patent
active
059985984
ABSTRACT:
The invention is directed toward a compound comprising a recombinant nucleic acid encoding an immunoadhesin inserted within an adenoviral nucleic acid, wherein the recombinant nucleic acid can be packaged in an adenovirus particle and wherein expression of the recombinant nucleic acid encoding the immunoadhesin results in production of the immunoadhesin protein. The recombinant nucleic acid encoding the immunoadhesin can be within an adenovirus. The invention further provides methods for delivering an immunoadhesin to a cell or a subject comprising administering to the cell or the subject an adenovirus comprising a recombinant nucleic acid encoding an immunoadhesin; producing an immunoadhesin comprising administering to a cell an adenovirus comprising a recombinant nucleic acid encoding an immunoadhesin inserted within an adenoviral nucleic acid, whereby the cell expresses the recombinant nucleic acid encoding the immunoadhesin, thereby producing the immunoadhesin; treating an inflammatory condition in a subject comprising administering to the subject an adenovirus comprising a recombinant nucleic acid encoding an immunoadhesin inserted within an adenoviral nucleic acid or a recombinant nucleic acid encoding an immunoadhesin inserted within an adenoviral nucleic acid, whereby a cell in the subject expresses the recombinant nucleic acid encoding the immunoadhesin and produces the immunoadhesin, thereby treating the inflammatory condition or administering to the subject a recombinant nucleic acid encoding an immunoadhesin, or an immunoadhesin, wherein the immunoadhesin is selected from the group consisting of vIL-10-IgG, IL-13-IgG, LFA-IgG, IL-2ra-IgG, IL-1ra-IgG, mutant IL-4-IgG, VLA4-IgG, IL-2-IgG, TGF-.beta.1-IgG, TGF-.beta.1.sup.223,225 -IgG, and VCAM-IgG; and methods of screening an immunoadhesin for bioactivity.
REFERENCES:
patent: 5316921 (1994-05-01), Godowski et al.
Aruffo et al. "CD44 is the principal cell surface receptor for hyaluronate" Cell 61(7), 1303-13 (1990).
Haak-Frendscho et al. "Human IgE receptor .alpha.-chain lgG chimera blocks passive cutaneous anaphylaxis reaction in vivo" J Immunol 151(1), 351-8 (1993).
Hannum et al. "Interleukin-1 Receptor Antagonist Activity of a Human Interleukin-1 Inhibitor" Nature 343:336-40 (1990).
LaRochelle et al. "Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera" J Cell Biol 129(2), 357-66 (1995).
Levrero et al. "Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo" Gene 101(2), 195-202 (1991).
Linsley et al. "Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation" J Exp Med 173(3), 721-30 (1991).
McGrory et al. "A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5" Virology 163:614-617 (1988).
Sullivan et al. "Adenovirus-mediated gene transfer of ornithine aminotransferase in cultured human retinal pigment epithelium" Invest Ophthalmol Vis Sci 37(5), 766-74 (1996).
Yang et al. "Construction and adhesive properties of a slouble MAdCAM-1-Fc chimera expressed in a baculovirus: phylogenetic conservation of receptor-ligand interaction" Scand. J. Immunol. 42:235-247 (1995).
Zheng et al. "Administration of noncytolytic IL-10/Fc in murine models of liposaccharide-induced septic shock and allogeneic islet transplantation" J. Immunol. 154:5590-5600 (1995).
Kollis et al. "Influence of Adenoviral-Mediated Gene Transfer of a TNF Soluble Receptor on Pulmonary host Defenses" J. Investigative Med., Abstract XP-002082459, 43:41a, 1995.
Anglade Eddy
Csaky Karl G.
Larochelle William
Sullivan Daniel M.
Johnson Nancy A.
The United States of America as represented by the Department o
LandOfFree
Immunoadhesins and methods of production and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoadhesins and methods of production and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoadhesins and methods of production and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-825354